Estimating the opportunity–cost-based cost–effectiveness threshold: a peek behind the podcast
At ISPOR Europe (2–6 November 2019; Copenhagen, Denmark) we filmed an exclusive panel discussion between ISPOR President Nancy Devlin (University of Melbourne, Australia), James Lomas (University of York, UK), Danny Palnoch (NHS England, UK) and Martin Henriksson (Linköping University, Sweden).
Please sign in or register for FREE
Sign in to The Evidence Base®
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>